Drawing for LIFEDX

USPTO serial 88698468

LIFEDX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
COUGHLAN, REBECCA D.
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LIFEDX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian Spross

Brian Spross JONES & SPROSS, PLLC1605 LAKECLIFF HILLS LANESUITE 100AUSTIN, TX 78732

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes; Biological and chemical test kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for testing of bodily fluids and substances extracted from bodily fluids, namely, cells, proteins, small molecules, nucleotides, and nucleic acids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseasesACTIVE—
009Downloadable mobile software application for recording, analysis, storage, manipulation, and organization of wellness testing and health condition testing data; Downloadable mobile software application for communicating medical test results to patients and medical and healthcare service providers; Downloadable mobile software application for medical and laboratory appointment scheduling; Downloadable mobile software application for medical diagnostics testing and monitoring and for communicating medical test results to patients and service providers in the medical and healthcare fields; Downloadable publications in the nature of electronic reports in the fields of wellness testing and health condition testingACTIVE—
010Medical devices for monitoring oxymetory, gas analysis, vital signs, blood properties and respiratory events and system that transmit the data through the Internet; Medical diagnostic apparatus for analyzing and measuring electrolytes in the body; Medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters; Apparatus for blood analysis; Devices for measuring blood sugar for medical purposes; Medical diagnostic instruments for obtaining and analyzing of body fluid samples; Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical apparatus for diagnostic use, namely, apparatus for medical diagnostic testing of health conditions, diseases, or abnormalities, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for diagnostic use in the nature of wellness testing, health condition testing, and healthcare testing, namely, apparatus for medical diagnostic testing in the nature of point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, in the nature of apparatus for DNA and RNA testing for medical purposesACTIVE—
041Providing an online resource center in the nature of on-line journals, namely, blogs in the fields of healthcare, medicine, diagnostics, and personal health and fitnessACTIVE—
044Medical diagnostic testing, monitoring and reporting services; Medical information; Healthcare services, namely, the diagnosis of diseases, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing wellness information in the fields of health and wellness; Medical services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample in the nature of medical testing for diagnostic or treatment purposes; Providing a web site featuring medical informationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 11, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 11, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 15, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 15, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 15, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 15, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 23, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 22, 2021EX3GSOU EXTENSION 3 GRANTED—
Dec 17, 2021NREVNOTICE OF REVIVAL - E-MAILED—
Dec 16, 2021TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Dec 16, 2021PETGPETITION TO REVIVE-GRANTED—
Dec 16, 2021PROATEAS PETITION TO REVIVE RECEIVED—
Dec 9, 2021EXT3SOU EXTENSION 3 FILED—
Jun 11, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 9, 2021EX2GSOU EXTENSION 2 GRANTED—
Jun 9, 2021EXT2SOU EXTENSION 2 FILED—
Jun 9, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 23, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 22, 2021EX1GSOU EXTENSION 1 GRANTED—
Mar 22, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 10, 2021NREVNOTICE OF REVIVAL - E-MAILED—
Jan 8, 2021TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Jan 8, 2021PETGPETITION TO REVIVE-GRANTED—
Jan 8, 2021PROATEAS PETITION TO REVIVE RECEIVED—
Dec 9, 2020EXT1SOU EXTENSION 1 FILED—
Jun 9, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 14, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 25, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 11, 2020ALIEASSIGNED TO LIE—
Mar 4, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 2, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Mar 2, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 2, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 2, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 24, 2020DOCKASSIGNED TO EXAMINER—
Nov 26, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 22, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance